Anderman Jonathan

Anderman Jonathan is listed in filings as General Counsel at Compass Therapeutics, Inc.. This profile follows SEC Form 4 activity through Apr 30, 2026, including purchase activity. Recent filings connect the profile to Compass Therapeutics, Inc. (CMPX). The current snapshot covers public activity from Aug 14, 2024 to Apr 30, 2026. Reported amounts are shown as $47.3K to $775.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.